dc.contributor.author | Maurer, Florian P | |
dc.contributor.author | Shubladze, Natalia | |
dc.contributor.author | Kalmambetova, Gulmira | |
dc.contributor.author | Felker, Irina | |
dc.contributor.author | Kuchukhidze, Giorgi | |
dc.contributor.author | Drobniewski, Francis | |
dc.contributor.author | Yedilbayev, Askar | |
dc.contributor.author | Ehsani, Soudeh | |
dc.contributor.author | European Laboratory Initiative on TB, HIV and Viral Hepatitis | |
dc.contributor.author | Avellón, Ana | |
dc.date.accessioned | 2022-09-21T07:23:51Z | |
dc.date.available | 2022-09-21T07:23:51Z | |
dc.date.issued | 2021-06 | |
dc.identifier.citation | Euro Surveill. 2021 Jun;26(24):2100426. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/15004 | |
dc.description.abstract | We assessed the impact of COVID-19 on diagnostic services for tuberculosis (TB) by national reference laboratories in the WHO European Region. Of 35 laboratories, 30 reported declines in TB sample numbers, amounting up to > 50% of the pre-COVID-19 volumes. Sixteen reported reagent or consumable shortages. Nineteen reallocated ressources to SARS-CoV-2 testing, resulting in an overall increase in workload, largely without a concomitant increase in personnel (n = 14). This poses a risk to meeting the 2025 milestones of the End TB Strategy. | es_ES |
dc.description.sponsorship | Financial support for this work has been provided by the German Government. | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | European Centre for Disease Prevention and Control (ECDC) | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.subject | PCR | es_ES |
dc.subject | SARS-CoV-2 | es_ES |
dc.subject | Diagnostics | es_ES |
dc.subject.mesh | COVID-19 | es_ES |
dc.subject.mesh | Tuberculosis | es_ES |
dc.subject.mesh | COVID-19 Testing | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Laboratories | es_ES |
dc.subject.mesh | Pandemics | es_ES |
dc.subject.mesh | SARS-CoV-2 | es_ES |
dc.subject.mesh | World Health Organization | es_ES |
dc.title | Impact of the COVID-19 pandemic on tuberculosis national reference laboratory services in the WHO European Region, March to November 2020 | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.identifier.pubmedID | 34142651 | es_ES |
dc.format.volume | 26 | es_ES |
dc.format.number | 24 | es_ES |
dc.format.page | 2100426 | es_ES |
dc.identifier.doi | 10.2807/1560-7917.ES.2021.26.24.2100426 | es_ES |
dc.contributor.funder | German Government | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 1560-7917 | es_ES |
dc.relation.publisherversion | http://dx.doi.org/10.2807/1560-7917.ES.2021.26.24.2100426 | es_ES |
dc.identifier.journal | Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin | es_ES |
dc.repisalud.centro | ISCIII::Centro Nacional de Microbiología | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |